101495-37-8

Basic information

• Product Name: (3-(chlorocarbonyl)-5-nitrophenyl)boronic acid
• Synonyms: (3-(chlorocarbonyl)-5-nitrophenyl)boronic acid
• CAS NO: 101495-37-8
• Molecular Weight: 229.384
• Mol File: 101495-37-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3-(chlorocarbonyl)-5-nitrophenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3-(chlorocarbonyl)-5-nitrophenyl)boronic acid(101495-37-8)
• EPA Substance Registry System: (3-(chlorocarbonyl)-5-nitrophenyl)boronic acid(101495-37-8)

Safety Data

• Hazardous Substances Data: 101495-37-8(Hazardous Substances Data)

Upstream product

• 101084-81-5 (3-carboxy-5-nitrophenyl)boronic acid 

Downstream Products

• 851667-19-1 tris-(3-borono-5-nitrobenzoic acid)-triethanolamine ester 
• 693235-40-4 C₂₀H₁₆B₂N₄O₁₀ 
• 827300-03-8 tris-(3-borono-5-nitrobenzoic acid)-1,3,5-trihydroxybenzene ester 
• 693235-36-8 3-borono-5-nitrobenzoic acid 1,4-phenylene ester 
• 851667-20-4 3-borono-5-nitrobenzoyl-L-phenylalanine ethyl ester 
• 827299-64-9 3-(4-nitrophenoxycarbonyl)-5-nitrophenylboronic acid 

Relevant articles and documents

NANOPARTICLES FOR CROSSING THE BLOOD BRAIN BARRIER AND METHODS OF TREATMENT USING THE SAME

The present application discloses nanoparticles carrying therapeutic agents, including chemotherapeutic agents, and targeting ligands suitable for delivering these therapeutic agents through the blood brain barrier and methods of using these patients on t

NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS

Described herein are carrier nanoparticles comprising a polymer containing a polyol coupled to a polymer containing a boronic acid, configured to present the polymer containing a boronic acid to an environment external to the nanoparticle. Targeted versions of the described nanoparticles are also described, as are related compositions, methods and systems.

INHIBITORS OF CORONAVIRUS PROTEASE AND METHODS OF USE THEREOF

This invention provides organic boron-containing compounds, compositions thereof, and methods of using such compounds and compositions for inhibiting coronavirus protease(s) and for treating infections.